Clinical Trials Logo

Influenza Prevention clinical trials

View clinical trials related to Influenza Prevention.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05901636 Active, not recruiting - Clinical trials for Influenza Prevention

A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults

Start date: May 17, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The primary purpose of this study is to evaluate safety/ reactogenicity of INFLUENZA G1 mini-hemagglutinin stem-derived protein vaccine antigen (mHA), with or without Al(OH)3 adjuvant, in healthy adults greater than or equal to (>=) 18 to less than or equal to (<=) 45 years of age.